Floatz logo

Cholesterol Suspension

Autism

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Autism cohort.

Asset / SponsorPhaseRating
Lurasidone
Sumitomo Pharma America, Inc.
Phase 3BB
Rapamycin
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase 2B
Everolimus
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase 2B
Sertraline
Holland Bloorview Kids Rehabilitation Hospital
Phase 2CCC
Opc-34712
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 1CC
FLUOXETINE
Icahn School of Medicine at Mount Sinai
N/AD

Same molecule, other indications

Cholesterol Suspension is also rated in:

Smith-Lemli-Opitz syndromeDormant
BB
Indicative ·
64 / 100
View asset →
atypical autismDormant
NR
Indicative ·
/ 100
View asset →
autism spectrum disorder 1Dormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →